Skip to main content
Premium Trial:

Request an Annual Quote

Scottish Universities Awarded 11.5M Pounds For Structural Proteomics

NEW YORK, June 18 (GenomeWeb News) - Three Scottish universities have been awarded nearly £11.5 million ( $21.1 million) for structural proteomics programs, the UK Biotechnology and Biological Sciences Research Council announced Thursday.


The funding, which is part of the council's Structural Proteomics of Rational Targets Initiative, includes over £6.8 million to go to the Membrane Protein Structure Initiative, a trans-UK effort led by Neil Isaacs of the University of Glasgow, and over £4.6 million will go to a structural proteomics facility that is a joint project of the Universities of St. Andrews and Dundee, for a multidisciplinary molecular and chemical biology scientific program, the BBSRC said.


The Membrane Protein Structure Initiative has the goal of developing strategies to increase understanding of cell membrane proteins, especially those that are molecular transporters.


BBSRC has £49 million in UK funds awarded in 2002, £14 million of which has been earmarked for structural proteomics.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.